Integrated extracellular matrix signaling in mammary gland development and breast cancer progression

Histology and Histopathology

Volumn 29, Issue 9, 2014, Pages 1083-1092

  Zhu, Jieqing ^a   Xiong, Gaofeng ^a   Trinkle, Christine ^c   Xu, Ren ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Department of Molecular and Biomedical Pharmacology ^*  (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Breast cancer progression; Extracellular matrix; Mammary gland development; Mechano transduction

Indexed keywords

BREAST TUMOR; DISEASE COURSE; EMBRYOLOGY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; MAMMARY GLAND; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; SIGNAL TRANSDUCTION;

EID: 84905662673     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. Akalu A. and Brooks P.C. (2004). Matrix, extracellular and interstitial. In: Encyclopedia of molecular cell biology and molecular medicine. 2nd ed. Meyers R.A. (ed). Wiley-VCH Verlag. Weinheim.
2. Akhtar N. and Streuli C.H. (2006). Rac1 links integrin-mediated adhesion to the control of lactational differentiation in mammary epithelia. J. Cell Biol. 173, 781-793.
3. Alcaraz J., Xu R., Mori H., Nelson C.M., Mroue R., Spencer V.A., Brownfield D., Radisky D.C., Bustamante C. and Bissell M.J. (2008). Laminin and biomimetic extracellular elasticity enhance functional differentiation in mammary epithelia. EMBO J. 27, 2829-2838.
4. Amenta P.S., Hadad S., Lee M.T., Barnard N., Li D. and Myers J.C. (2003). Loss of types xv and xix collagen precedes basement membrane invasion in ductal carcinoma of the female breast. J. Pathol. 199, 298-308.
5. Aumailley M., Bruckner-Tuderman L., Carter W.G., Deutzmann R., Edgar D., Ekblom P., Engel J., Engvall E., Hohenester E., Jones J.C., Kleinman H.K., Marinkovich M.P., Martin G.R., Mayer U., Meneguzzi G., Miner J.H., Miyazaki K., Patarroyo M., Paulsson M., Quaranta V., Sanes J.R., Sasaki T., Sekiguchi K., Sorokin L.M., Talts J.F., Tryggvason K., Uitto J., Virtanen I., von der Mark K., Wewer U.M., Yamada Y. and Yurchenco P.D. (2005). A simplified laminin nomenclature. Matrix Biol. 24, 326-332.
6. Barcellos-Hoff M.H., Aggeler J., Ram T.G. and Bissell M.J. (1989). Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development 105, 223-235.
7. Barcus C.E., Keely P.J., Eliceiri K.W. and Schuler L.A. (2013). Stiff collagen matrices increase tumorigenic prolactin signaling in breast cancer cells. J. Biol. Chem. 288, 12722-12732.
8. Bergers G., Brekken R., McMahon G., Vu T.H., Itoh T., Tamaki K., Tanzawa K., Thorpe P., Itohara S., Werb Z. and Hanahan D. (2000). Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2, 737-744.
9. Bissell M.J., Hall H.G. and Parry G. (1982). How does the extracellular matrix direct gene expression? J. Theor. Biol. 99, 31-68.
10. Brownfield D.G., Venugopalan G., Lo A., Mori H., Tanner K., Fletcher D.A. and Bissell M.J. (2013). Patterned collagen fibers orient branching mammary epithelium through distinct signaling modules. Curr. Biol. CB 23, 703-709.
11. Calvo F., Ege N., Grande-Garcia A., Hooper S., Jenkins R.P., Chaudhry S.I., Harrington K., Williamson P., Moeendarbary E., Charras G. and Sahai E. (2013). Mechanotransduction and yap-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat. Cell Biol. 15, 637-646.
12. Cantley L.C. (2002). The phosphoinositide 3-kinase pathway. Science 296, 1655-1657.
13. Carpenter P.M., Dao A.V., Arain Z.S., Chang M.K., Nguyen H.P., Arain S., Wang-Rodriguez J., Kwon S.Y. and Wilczynski S.P. (2009). Motility induction in breast carcinoma by mammary epithelial laminin 332 (laminin 5). Mol. Cancer Res. 7, 462-475.
14. Chen C.C., Stairs D.B., Boxer R.B., Belka G.K., Horseman N.D., Alvarez J.V. and Chodosh L.A. (2012). Autocrine prolactin induced by the pten-akt pathway is required for lactation initiation and provides a direct link between the akt and stat5 pathways. Genes Dev. 26, 2154-2168.
15. Christensen L. (1992). The distribution of fibronectin, laminin and tetranectin in human breast cancer with special attention to the extracellular matrix. APMIS. Supplementum 26, 1-39.
16. Colorado P.C., Torre A., Kamphaus G., Maeshima Y., Hopfer H., Takahashi K., Volk R., Zamborsky E.D., Herman S., Sarkar P.K., Ericksen M.B., Dhanabal M., Simons M., Post M., Kufe D.W., Weichselbaum R.R., Sukhatme V.P. and Kalluri R. (2000). Antiangiogenic cues from vascular basement membrane collagen. Cancer Res. 60, 2520-2526.
17. Conklin M.W., Eickhoff J.C., Riching K.M., Pehlke C.A., Eliceiri K.W., Provenzano P.P., Friedl A. and Keely P.J. (2011). Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am. J. Pathol. 178, 1221-1232.
18. Contie S., Voorzanger-Rousselot N., Litvin J., Clezardin P. and Garnero P. (2011). Increased expression and serum levels of the stromal cell-secreted protein periostin in breast cancer bone metastases. International journal of cancer. Int. J. Cancer 128, 352-360.
19. Cox T.R. and Erler J.T. (2011). Remodeling and homeostasis of the extracellular matrix: Implications for fibrotic diseases and cancer. Dis. Model. Mech. 4, 165-178.
20. Dupont S., Morsut L., Aragona M., Enzo E., Giulitti S., Cordenonsi M., Zanconato F., Le Digabel J., Forcato M., Bicciato S., Elvassore N. and Piccolo S. (2011). Role of yap/taz in mechanotransduction. Nature 474, 179-183.
21. Engelman J.A., Luo J. and Cantley L.C. (2006). The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7, 606-619.
22. Ewald A.J., Brenot A., Duong M., Chan B.S. and Werb Z. (2008). Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev. Cell 14, 570-581.
23. Gaggar A., Jackson P.L., Noerager B.D., O'Reilly P.J., McQuaid D.B., Rowe S.M., Clancy J.P. and Blalock J.E. (2008). A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J. Immunol. 180, 5662-5669.
24. Gilkes D.M., Bajpai S., Chaturvedi P., Wirtz D. and Semenza G.L. (2013a). Hypoxia-inducible factor 1 (hif-1) promotes extracellular matrix remodeling under hypoxic conditions by inducing p4ha1, p4ha2, and plod2 expression in fibroblasts. J. Biol. Chem. 288, 10819-10829.
25. Gilkes D.M., Chaturvedi P., Bajpai S., Wong C.C., Wei H., Pitcairn S., Hubbi M.E., Wirtz D. and Semenza G.L. (2013b). Collagen prolyl hydroxylases are essential for breast cancer metastasis. Cancer Res. 73, 3285-3296.
26. Gillan L., Matei D., Fishman D.A., Gerbin C.S., Karlan B.Y. and Chang D.D. (2002). Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(v)beta(3) and alpha(v)beta(5) integrins and promotes cell motility. Cancer Res. 62, 5358-5364.
27. Goffin V., Binart N., Touraine P. and Kelly P.A. (2002). Prolactin: The new biology of an old hormone. Annu. Rev. Physiol. 64, 47-67.
28. Gouilleux F., Wakao H., Mundt M. and Groner B. (1994). Prolactin induces phosphorylation of tyr694 of stat5 (mgf), a prerequisite for DNA binding and induction of transcription. EMBO J. 13, 4361-4369.
29. Gouilleux F., Pallard C., Dusanter-Fourt I., Wakao H., Haldosen L.A., Norstedt G., Levy D. and Groner B. (1995). Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce mgf-stat5 DNA binding activity. EMBO J. 14, 2005-2013.
30. Guo W. and Giancotti F.G. (2004). Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 5, 816-826.
31. Guo W., Pylayeva Y., Pepe A., Yoshioka T., Muller W.J., Inghirami G. and Giancotti F.G. (2006). Beta 4 integrin amplifies erbb2 signaling to promote mammary tumorigenesis. Cell 126, 489-502.
32. Ingman W.V., Wyckoff J., Gouon-Evans V., Condeelis J. and Pollard J.W. (2006). Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland. Dev. Dyn. 235, 3222-3229.
33. Iyengar P., Espina V., Williams T.W., Lin Y., Berry D., Jelicks L.A., Lee H., Temple K., Graves R., Pollard J., Chopra N., Russell R.G., Sasisekharan R., Trock B.J., Lippman M., Calvert V.S., Petricoin E.F., 3rd, Liotta L., Dadachova E., Pestell R.G., Lisanti M.P., Bonaldo P. and Scherer P.E. (2005). Adipocyte-derived collagen vi affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J. Clin. Invest. 115, 1163-1176.
34. Kagan H.M. and Li W. (2003). Lysyl oxidase: Properties, specificity, and biological roles inside and outside of the cell. J. Cell Biochem. 88, 660-672.
35. Kashyap A.S., Hollier B.G., Manton K.J., Satyamoorthy K., Leavesley D.I. and Upton Z. (2011). Insulin-like growth factor-i:Vitronectin complex-induced changes in gene expression effect breast cell survival and migration. Endocrinology 152, 1388-1401.
36. Kauppila S., Stenback F., Risteli J., Jukkola A. and Risteli L. (1998). Aberrant type i and type iii collagen gene expression in human breast cancer in vivo. J. Pathol. 186, 262-268.
37. Keely P.J., Wu J.E. and Santoro S.A. (1995). The spatial and temporal expression of the alpha 2 beta 1 integrin and its ligands, collagen i, collagen iv, and laminin, suggest important roles in mouse mammary morphogenesis. Differentiation 59, 1-13.
38. Koblinski J.E., Kaplan-Singer B.R., VanOsdol S.J., Wu M., Engbring J.A., Wang S., Goldsmith C.M., Piper J.T., Vostal J.G., Harms J.F., Welch D.R. and Kleinman H.K. (2005). Endogenous osteonectin/sparc/bm-40 expression inhibits mda-mb-231 breast cancer cell metastasis. Cancer Res. 65, 7370-7377.
39. Kolsch V., Charest P.G. and Firtel R.A. (2008). The regulation of cell motility and chemotaxis by phospholipid signaling. J. Cell Sci. 121, 551-559.
40. Lahlou H., Muller T., Sanguin-Gendreau V., Birchmeier C. and Muller W.J. (2012). Uncoupling of pi3k from erbb3 impairs mammary gland development but does not impact on erbb2-induced mammary tumorigenesis. Cancer Res. 72, 3080-3090.
41. Le Beyec J., Xu R., Lee S.Y., Nelson C.M., Rizki A., Alcaraz J. and Bissell M.J. (2007). Cell shape regulates global histone acetylation in human mammary epithelial cells. Exp. Cell Res. 313, 3066-3075.
42. Leonoudakis D., Singh M., Mohajer R., Mohajer P., Fata J.E., Campbell K.P. and Muschler J.L. (2010). Dystroglycan controls signaling of multiple hormones through modulation of stat5 activity. J. Cell Sci. 123, 3683-3692.
43. Levental K.R., Yu H., Kass L., Lakins J.N., Egeblad M., Erler J.T., Fong S.F., Csiszar K., Giaccia A., Weninger W., Yamauchi M., Gasser D.L. and Weaver V.M. (2009). Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139, 891-906.
44. Liotta L.A., Tryggvason K., Garbisa S., Hart I., Foltz C.M. and Shafie S. (1980). Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284, 67-68.
45. Liu X., Robinson G.W., Wagner K.U., Garrett L., Wynshaw-Boris A. and Hennighausen L. (1997). Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11, 179-186.
46. Liu H., Radisky D.C., Wang F. and Bissell M.J. (2004). Polarity and proliferation are controlled by distinct signaling pathways downstream of pi3-kinase in breast epithelial tumor cells. J. Biol. Chem. 164, 603-612.
47. Luparello C. and Sirchia R. (2005). Type v collagen regulates the expression of apoptotic and stress response genes by breast cancer cells. J. Cell. Physiol. 202, 411-421.
48. Luparello C., David F., Campisi G. and Sirchia R. (2003). T47-d cells and type v collagen: A model for the study of apoptotic gene expression by breast cancer cells. Biol. Chem. 384, 965-975.
49. Malanchi I., Santamaria-Martinez A., Susanto E., Peng H., Lehr H.A., Delaloye J.F. and Huelsken J. (2012). Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481, 85-89.
50. Martin L.J. and Boyd N.F. (2008). Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: Hypotheses based on epidemiological evidence. Breast Cancer Res. 10, 201.
51. McCormack V.A. and dos Santos Silva I. (2006). Breast density and parenchymal patterns as markers of breast cancer risk: A metaanalysis. Cancer Epidemiol. Biomarkers Prev. 15, 1159-1169.
52. Mollenhauer J., Helmke B., Medina D., Bergmann G., Gassler N., Muller H., Lyer S., Diedrichs L., Renner M., Wittig R., Blaich S., Hamann U., Madsen J., Holmskov U., Bikker F., Ligtenberg A., Carlen A., Olsson J., Otto H.F., O'Malley B. and Poustka A. (2004). Carcinogen inducibility in vivoand down-regulation of dmbt1 during breast carcinogenesis. Genes Chromosomes Cancer 39, 185-194.
53. Mott J.D. and Werb Z. (2004). Regulation of matrix biology by matrix metalloproteinases. Curr. Opin. Cell Biol. 16, 558-564.
54. Naba A., Hoersch S. and Hynes R.O. (2012). Towards definition of an ecm parts list: An advance on go categories. Matrix Biol. 31, 371-372.
55. Nakano S., Iyama K., Ogawa M., Yoshioka H., Sado Y., Oohashi T. and Ninomiya Y. (1999). Differential tissular expression and localization of type iv collagen alpha1(iv), alpha2(iv), alpha5(iv), and alpha6(iv) chains and their mrna in normal breast and in benign and malignant breast tumors. Lab. Invest. 79, 281-292.
56. Naylor M.J., Li N., Cheung J., Lowe E.T., Lambert E., Marlow R., Wang P., Schatzmann F., Wintermantel T., Schuetz G., Clarke A.R., Mueller U., Hynes N.E. and Streuli C.H. (2005). Ablation of beta1 integrin in mammary epithelium reveals a key role for integrin in glandular morphogenesis and differentiation. J. Cell Biol. 171, 717-728.
57. Novaro V., Roskelley C.D. and Bissell M.J. (2003). Collagen-iv and laminin-1 regulate estrogen receptor alpha expression and function in mouse mammary epithelial cells. J. Cell Sci. 116, 2975-2986.
58. Ormandy C.J., Camus A., Barra J., Damotte D., Lucas B., Buteau H., Edery M., Brousse N., Babinet C., Binart N. and Kelly P.A. (1997). Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 11, 167-178.
59. Oskarsson T., Acharyya S., Zhang X.H., Vanharanta S., Tavazoie S.F., Morris P.G., Downey R.J., Manova-Todorova K., Brogi E. and Massague J. (2011). Breast cancer cells produce tenascin c as a metastatic niche component to colonize the lungs. Nat. Med. 17, 867-874.
60. Park J. and Schwarzbauer J.E. (2014). Mammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transition. Oncogene 33, 1649-1657.
61. Paszek M.J., Zahir N., Johnson K.R., Lakins J.N., Rozenberg G.I., Gefen A., Reinhart-King C.A., Margulies S.S., Dembo M., Boettiger D., Hammer D.A. and Weaver V.M. (2005). Tensional homeostasis and the malignant phenotype. Cancer Cell 8, 241-254.
62. Pickup M.W., Laklai H., Acerbi I., Owens P., Gorska A.E., Chytil A., Aakre M., Weaver V.M. and Moses H.L. (2013). Stromally derived lysyl oxidase promotes metastasis of transforming growth factorbeta-deficient mouse mammary carcinomas. Cancer Res. 73, 5336-5346.
63. Postovit L.M., Abbott D.E., Payne S.L., Wheaton W.W., Margaryan N.V., Sullivan R., Jansen M.K., Csiszar K., Hendrix M.J. and Kirschmann D.A. (2008). Hypoxia/reoxygenation: A dynamic regulator of lysyl oxidase-facilitated breast cancer migration. J. Cell. Biochem. 103, 1369-1378.
64. Prince J.M., Klinowska T.C., Marshman E., Lowe E.T., Mayer U., Miner J., Aberdam D., Vestweber D., Gusterson B. and Streuli C.H. (2002). Cell-matrix interactions during development and apoptosis of the mouse mammary gland in vivo. Dev. Dyn. 223, 497-516.
65. Provenzano P.P., Inman D.R., Eliceiri K.W., Knittel J.G., Yan L., Rueden C.T., White J.G. and Keely P.J. (2008). Collagen density promotes mammary tumor initiation and progression. BMC Med. 6, 11.
66. Pujuguet P., Simian M., Liaw J., Timpl R., Werb Z. and Bissell M.J. (2000). Nidogen-1 regulates laminin-1-dependent mammary-specific gene expression. J. Cell Sci. 113 (Pt 5), 849-858.
67. Saad S., Gottlieb D.J., Bradstock K.F., Overall C.M. and Bendall L.J. (2002). Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts. Cancer Res. 62, 283-289.
68. Saga Y., Yagi T., Ikawa Y., Sakakura T. and Aizawa S. (1992). Mice develop normally without tenascin. Genes Dev. 6, 1821-1831.
69. Sasaki H., Yu C.Y., Dai M., Tam C., Loda M., Auclair D., Chen L.B. and Elias A. (2003). Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer. Breast Cancer Res. Treat. 77, 245-252.
70. Shahbazian M.D. and Grunstein M. (2007). Functions of site-specific histone acetylation and deacetylation. Annu. Rev. Biochem. 76, 75-100.
71. Soltoff S.P., Carraway K.L. 3rd, Prigent S.A., Gullick W.G. and Cantley L.C. (1994). Erbb3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol. Cell. Biol. 14, 3550-3558.
72. Sternlicht M.D., Kouros-Mehr H., Lu P. and Werb Z. (2006). Hormonal and local control of mammary branching morphogenesis. Differentiation 74, 365-381.
73. Streuli C.H., Edwards G.M., Delcommenne M., Whitelaw C.B., Burdon T.G., Schindler C. and Watson C.J. (1995). Stat5 as a target for regulation by extracellular matrix. J. Biol. Chem. 270, 21639-21644.
74. Swift J., Ivanovska I.L., Buxboim A., Harada T., Dingal P.C., Pinter J., Pajerowski J.D., Spinler K.R., Shin J.W., Tewari M., Rehfeldt F., Speicher D.W. and Discher D.E. (2013). Nuclear lamin-a scales with tissue stiffness and enhances matrix-directed differentiation. Science 341, 1240104.
75. Utermark T., Rao T., Cheng H., Wang Q., Lee S.H., Wang Z.C., Iglehart J.D., Roberts T.M., Muller W.J. and Zhao J.J. (2012). The p110alpha and p110beta isoforms of pi3k play divergent roles in mammary gland development and tumorigenesis. Genes Dev. 26, 1573-1586.
76. Vanhaesebroeck B., Guillermet-Guibert J., Graupera M. and Bilanges B. (2010). The emerging mechanisms of isoform-specific pi3k signalling. Nat. Rev. Mol. Cell Biol. 11, 329-341.
77. Vlodavsky I., Miao H.Q., Medalion B., Danagher P. and Ron D. (1996). Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Met. Rev. 15, 177-186.
78. Vogel V. and Sheetz M. (2006). Local force and geometry sensing regulate cell functions. Nature reviews. Mol. Cell Biol. 7, 265-275.
79. Wang F., Weaver V.M., Petersen O.W., Larabell C.A., Dedhar S., Briand P., Lupu R. and Bissell M.J. (1998). Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biology. Proc. Natl. Acad. Sci. USA 95, 14821-14826.
80. Watkins G., Douglas-Jones A., Bryce R., Mansel R.E. and Jiang W.G. (2005). Increased levels of sparc (osteonectin) in human breast cancer tissues and its association with clinical outcomes. Prostaglandins Leukot. Essent. Fatty Acids. 72, 267-272.
81. Weathington N.M., van Houwelingen A.H., Noerager B.D., Jackson P.L., Kraneveld A.D., Galin F.S., Folkerts G., Nijkamp F.P. and Blalock J.E. (2006). A novel peptide cxcr ligand derived from extracellular matrix degradation during airway inflammation. Nat. Med. 12, 317-323.
82. Williams C.M., Engler A.J., Slone R.D., Galante L.L. and Schwarzbauer J.E. (2008). Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation. Cancer Res. 68, 3185-3192.
83. Woodward T.L., Mienaltowski A.S., Modi R.R., Bennett J.M. and Haslam S.Z. (2001). Fibronectin and the alpha(5)beta(1) integrin are under developmental and ovarian steroid regulation in the normal mouse mammary gland. Endocrinology 142, 3214-3222.
84. Wozniak M.A., Desai R., Solski P.A., Der C.J. and Keely P.J. (2003). Rock-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a threedimensional collagen matrix. J. Cell Biol. 163, 583-595.
85. Xiong G., Deng L., Zhu J., Rychahou P.G. and Xu R. (2014). Prolyl-4-hydroxylase alpha subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition. BMC Cancer 14, 1.
86. Xu R. and Mao J.H. (2011). Gene transcriptional networks integrate microenvironmental signals in human breast cancer. Integr. Biol. (Camb) 3, 368-374.
87. Xu R., Yao Z.Y., Xin L., Zhang Q., Li T.P. and Gan R.B. (2001). Nc1 domain of human type viii collagen (alpha 1) inhibits bovine aortic endothelial cell proliferation and causes cell apoptosis. Biochem. Biophys. Res. Commun. 289, 264-268.
88. Xu R., Spencer V.A. and Bissell M.J. (2007). Extracellular matrixregulated gene expression requires cooperation of swi/snf and transcription factors. J. Biol. Chem. 282, 14992-14999.
89. Xu R., Boudreau A. and Bissell M.J. (2009a). Tissue architecture and function: Dynamic reciprocity via extra-and intra-cellular matrices. Cancer Met. Rev. 28, 167-176.
90. Xu R., Nelson C.M., Muschler J.L., Veiseh M., Vonderhaar B.K. and Bissell M.J. (2009b). Sustained activation of stat5 is essential for chromatin remodeling and maintenance of mammary-specific function. J. Cell Biol. 184, 57-66.
91. Xu R., Spencer V.A., Groesser D.L. and Bissell M.J. (2010). Laminin regulates pi3k basal localization and activation to sustain stat5 activation. Cell Cycle 9, 4315-4322.
92. Yamauchi M. and Shiiba M. (2008). Lysine hydroxylation and crosslinking of collagen. Methods Mol. Biol. 446, 95-108.
93. Zhang K., Corsa C.A., Ponik S.M., Prior J.L., Piwnica-Worms D., Eliceiri K.W., Keely P.J. and Longmore G.D. (2013). The collagen receptor discoidin domain receptor 2 stabilizes snail1 to facilitate breast cancer metastasis. Nat. Cell Biol. 15, 677-687.
94. Zhu W. and Nelson C.M. (2013). Pi3k regulates branch initiation and extension of cultured mammary epithelia via akt and rac1 respectively. Dev. Biol. 379, 235-245.